Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

De-escalation Radiation Strategy After NAC in Combination With ICI in LAHNSCC — Stella

Home/Locally Advanced Head and Neck Squamous Cell Carcinoma/De-escalation Radiation Strategy After NAC in Combination With ICI in LAHNSCC

View on ClinicalTrials.gov

Recruiting

Back to Locally Advanced Head and Neck Squamous Cell Carcinoma trials

De-escalation Radiation Strategy After NAC in Combination With ICI in LAHNSCC

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

China

Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, Shanghai Municipality

Key details

Phase

Early testing / Safety & dosing

Sponsor

Ruijin Hospital

Enrollment target

~20 participants

Started

October 2023

Primary completion

September 2026

Age range

18 Years and older

Last updated August 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.